All lobbying filings

CAPITOL HILL CONSULTING GROUP

Lobbying for ASSOCIATION FOR ACCESSIBLE MEDICINES (FORMERLY GENERIC PHARMACEUTICAL ASSOC.) · National trade organization representing the interests of generic drug manufacturers.

Filing 4th Quarter - Termination

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $60,000.00 income · posted Jan 20, 2026

Official filing document

Bills named in this filing 1

S 43
Skinny Labels, Big Savings Act

Lobbying activity 4

Trade (domestic/foreign)

Issues related to potential tariffs on generic drugs.

Issues S. 43, Skinny Labels, Big Savings Act.

Health Issues

- Issues relating to the labeling of generic drugs. - Issues relating to the 180 day exclusivity for generics. - Issues related to medical supply chain, including supply chain safety. - Issues related to drug pricing including drug negotiation. - Issues related to Inflation Reduction Act. - Issues related to biosimilars. - Issues related to drug shortages.

Medicare/Medicaid

Issues related to the cost of prescription drugs. Issues pertaining to coverage and reimbursement of biosimilars. Issues related to Part D coverage of generic drugs, including Part D redesign. Issues relating to the impact of prescription drug negotiation on generic drugs and biosimilars. Issues related to Medicare Part D reform.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.